SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-008975
Filing Date
2024-02-01
Accepted
2024-02-01 16:01:33
Documents
16
Period of Report
2024-01-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192595-8k_fresh2group.htm   iXBRL 8-K 29838
2 PRESS RELEASE DATED JANUARY 31, 2024 ea192595ex99-1_fresh2group.htm EX-99.1 10787
  Complete submission text file 0001213900-24-008975.txt   259785

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE fres-20240131.xsd EX-101.SCH 3863
4 XBRL DEFINITION FILE fres-20240131_def.xml EX-101.DEF 26768
5 XBRL LABEL FILE fres-20240131_lab.xml EX-101.LAB 37014
6 XBRL PRESENTATION FILE fres-20240131_pre.xml EX-101.PRE 25392
17 EXTRACTED XBRL INSTANCE DOCUMENT ea192595-8k_fresh2group_htm.xml XML 5476
Mailing Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108
Business Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108 1 917-397-6890
Fresh2 Group Ltd (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 8-K | Act: 34 | File No.: 001-39137 | Film No.: 24586834
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)